3.17

1.93% 0.06

Niagen Bioscience Inc (NAGE)

Overview News Price History Discussions Forecast

Niagen Bioscience Inc stock is traded at $3.17, with a volume of 256.77K. It is up +1.93% in the last 24 hours and down -8.65% over the past month. Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Previous Close:

$3.11

Open:

$3.1

24h Volume:

256.77K

Relative Volume:

0.34

Market Cap:

$250.83M

Revenue:

$130.42M

Net Income/Loss:

$18.64M

P/E Ratio:

14.53

EPS:

0.2182

Net Cash Flow:

$4.05M

1W Performance:

-3.65%

1M Performance:

-8.65%

6M Performance:

-35.83%

1Y Performance:

-65.99%

1-Day Range:

$3.07

$3.17

1-Week Range:

$3.07

$3.275

52-Week Range:

$2.87

$10.52

Niagen Bioscience Inc Stock (NAGE) Company Profile

Name

Niagen Bioscience Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

310-388-6706

Address

10900 WILSHIRE BLVD, LOS ANGELES

Employee

117

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

NAGE's Discussions on Twitter

Compare NAGE vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NAGE Niagen Bioscience Inc	3.17	249.25M	130.42M	18.64M	4.05M	0.2182
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-27-25	Initiated	Canaccord Genuity	Buy
Aug-16-22	Downgrade	Oppenheimer	Outperform → Perform
Aug-11-22	Downgrade	B. Riley Securities	Buy → Neutral
Mar-08-22	Initiated	ROTH Capital	Buy
Oct-16-19	Initiated	Oppenheimer	Outperform
Feb-14-19	Initiated	B. Riley FBR	Buy
Nov-27-17	Resumed	H.C. Wainwright	Buy
Sep-25-17	Initiated	Ladenburg Thalmann	Buy
Jan-03-17	Initiated	Rodman & Renshaw	Buy

View All

Niagen Bioscience Inc Stock (NAGE) Latest News

Aug 21, 2026

Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India

Aug 20, 2026

Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News

Aug 20, 2026

Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat

Aug 20, 2026

Aug 19, 2026

Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn

Aug 18, 2026

Aug 15, 2026

Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet

Aug 15, 2026

Aug 14, 2026

Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine

Aug 14, 2026

Aug 13, 2026

Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn

Aug 13, 2026

Aug 12, 2026

Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget

Aug 12, 2026

Aug 11, 2026

Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India

Aug 11, 2026

Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com

Aug 11, 2026

Aug 08, 2026

Niagen Bioscience (NAGE) Gains Fresh Momentum, Is The Stock Still Cheap? - simplywall.st

Aug 08, 2026

Aug 07, 2026

HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat

Aug 07, 2026